REVISIONS TO PROFILE AND REFLEX COMPONENTS
Epilepsy, Autoimmune Evaluation, Serum
Order Code: EPS2
Fee Code: AA272 (CPT 86341), AA274 (CPT 86255) x16
Reference Laboratory: Mayo EPS2
Effective January 31, 2023, there will be additions and deletions to the profile and potential reflex tests for the Epilepsy, Autoimmune Evaluation, Serum referred to Mayo Clinic Laboratories as follows:
Testing to be added to Profile Information:
• NCDIS: Neurochondrin Antibody, Tissue Immunofluorescence, Serum (CPT 86255)
Testing to be added to Reflex Tests:
• AGNTS: Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1) Titer, Serum
• AN1TS: Antineuronal Nuclear Antibody-Type 1 (ANNA-1) Titer, Serum
• AN2TS: Antineuronal Nuclear Antibody Type 2 (ANNA-2) Titer, Serum
• AN3TS: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Serum
• APHTS: Amphiphysin Antibody Titer Assay, Serum
• CRMTS: Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum
• NCDCS: Neurochondrin Antibody, Cell-Binding Assay, Serum
• NCDTS: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Serum
• PC2TS: Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Serum
• PCTTS: Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) Titer, Serum
Testing to be removed from Reflex Tests:
• ARBI: Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum
• PC1BS: Purkinje Cell Cytoplasmic Antibody-Type 1, Immunoblot, Serum
• PCABP: Purkinje Cell Cytoplasmic Antibody, Type 1 (PCA-1), Serum